Description
Jardiance (Empagliflozin) 25mg tablets are an oral medication used primarily for the management of type 2 diabetes in adults. As an inhibitor of the sodium-glucose co-transporter 2 (SGLT2), Jardiance works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine and lowering blood glucose levels. Additionally, Jardiance has been shown to provide cardiovascular benefits and reduce the risk of hospitalization for heart failure in patients with type 2 diabetes.
Dosage/Direction
The typical starting dose of Jardiance is 10mg once daily, which may be increased to 25mg after assessing the patient’s tolerance and blood glucose levels. It can be taken with or without food, and patients are advised to take the tablet at the same time each day for optimal results. As with any medication, it’s essential to follow the prescribing healthcare provider’s instructions for use.
Side Effects
Common side effects of Jardiance may include urinary tract infections, genital fungal infections, increased urination, and dehydration. Rare but serious side effects can include kidney problems, ketoacidosis, and serious allergic reactions. Patients should report any unusual symptoms or side effects to their healthcare provider.
